Inhibikase Therapeutics, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders' Equity - Additional Information (Details)

Stockholders' Equity - Additional Information (Details)					3 Months Ended	12 Months Ended
Stockholders' Equity - Additional Information (Details)	Oct. 21, 2024 USD ($) $ / shares shares	May 20, 2024 USD ($) $ / shares shares	Jan. 31, 2023 USD ($)	Jan. 25, 2023 $ / shares shares	Mar. 31, 2023 USD ($)	Dec. 31, 2024 USD ($) Vote shares	Dec. 31, 2023 USD ($) shares	Sep. 30, 2024 shares	Sep. 30, 2023 USD ($) shares	Jun. 15, 2021 $ / shares shares	Dec. 28, 2020 $ / shares shares	Aug. 25, 2020 $ / shares shares	Mar. 31, 2020 $ / shares shares	Jan. 01, 2019 $ / shares shares	Oct. 27, 2018 $ / shares shares
Class Of Stock [Line Items]
Votes per each common stock share \| Vote						1
Common stock shares reserved for issuance \| shares						15,106,412
Class of warrant or right number of securities called by warrants or rights \| shares				1,937,985						125,000	17,073	3,643	4,371	3,423	66,811
Warrants exercise price										$ 22.5	$ 60	$ 35.42	$ 34.04	$ 28.76	$ 28.76
Fair value of stock \| $							$ 14,280		$ 17,280
Proceeds from issuance of common stock, pre-funded warrants and warrants, net of issuance costs \| $			$ 8,500,000			$ 103,477,668	$ 8,543,559
Initial fair value of Warrants \| $					$ 1,800,000
Shares issued \| shares							12,000		12,000
Series A-1 Warrants [Member]
Class Of Stock [Line Items]
Warrants exercise price	$ 1.37
Series A-1 Warrants [Member] \| October 2024 Offering [Member]
Class Of Stock [Line Items]
Warrants exercise price	1.37
Series B-1 Warrants [Member]
Class Of Stock [Line Items]
Warrants exercise price	1.49
Series B-1 Warrants [Member] \| October 2024 Offering [Member]
Class Of Stock [Line Items]
Warrants exercise price	$ 1.49
Warrant Inducement Agreement [Member] \| Series C Preferred Stock [Member]
Class Of Stock [Line Items]
Class of warrant or right number of securities called by warrants or rights \| shares		1,229,484
Warrants exercise price		$ 1.68
Common Stock [Member]
Class Of Stock [Line Items]
Sale of common stock per Share				$ 5.16
Issuance of common stock, Shares \| shares				466,799
Common Stock [Member] \| Warrant Inducement Agreement [Member]
Class Of Stock [Line Items]
Class of warrant or right number of securities called by warrants or rights \| shares		708,500
Warrants exercise price		$ 1.68
Common Stock [Member] \| Warrant Inducement Agreement [Member] \| Series C Preferred Stock [Member]
Class Of Stock [Line Items]
Class of warrant or right number of securities called by warrants or rights \| shares		708,500
Common Stock [Member] \| Warrant Inducement Agreement [Member] \| Series D Preferred Stock [Member]
Class Of Stock [Line Items]
Class of warrant or right number of securities called by warrants or rights \| shares		708,500
Warrants exercise price		$ 1.68
Warrant [Member]
Class Of Stock [Line Items]
Class of warrant or right number of securities called by warrants or rights \| shares	21,985,000	710,000				708,500	1,471,187	247,925				25,000
Warrants exercise price	$ 0.001			$ 5.16
Proceeds from issuance of common stock, pre-funded warrants and warrants, net of issuance costs \| $					$ 1,000,000
Warrant [Member] \| October 2024 Offering [Member]
Class Of Stock [Line Items]
Sale of common stock per Share	$ 1.37
Class of warrant or right number of securities called by warrants or rights \| shares	21,985,000
Warrants exercise price	$ 0.001
Issuance of common stock, Shares \| shares	58,310,000
Warrant [Member] \| Series A-1 Warrants [Member]
Class Of Stock [Line Items]
Class of warrant or right number of securities called by warrants or rights \| shares	40,139,474
Warrants exercise price	$ 1.37
Warrant [Member] \| Series A-1 Warrants [Member] \| October 2024 Offering [Member]
Class Of Stock [Line Items]
Class of warrant or right number of securities called by warrants or rights \| shares	40,139,474
Warrants exercise price	$ 1.37
Warrant [Member] \| Series B-1 Warrants [Member]
Class Of Stock [Line Items]
Class of warrant or right number of securities called by warrants or rights \| shares	73,813,529
Warrants exercise price	$ 1.37
Warrant [Member] \| Series B-1 Warrants [Member] \| October 2024 Offering [Member]
Class Of Stock [Line Items]
Class of warrant or right number of securities called by warrants or rights \| shares	73,813,529
Warrants exercise price	$ 1.37
Warrant [Member] \| Securities Purchase Agreements [Member]
Class Of Stock [Line Items]
Sale of common stock per Share		$ 1.68
Class of warrant or right number of securities called by warrants or rights \| shares		957,925
Warrants exercise price		$ 0.0001
Issuance of common stock, Shares \| shares		714,527
Proceeds from issuance of common stock, pre-funded warrants and warrants, net of issuance costs \| $		$ 2,200,000
Warrant [Member] \| Securities Purchase Agreements [Member] \| Series A Preferred Stock [Member]
Class Of Stock [Line Items]
Class of warrant or right number of securities called by warrants or rights \| shares		1,672,452
Warrants exercise price		$ 1.68
Warrant [Member] \| Securities Purchase Agreements [Member] \| Series B Preferred Stock [Member]
Class Of Stock [Line Items]
Class of warrant or right number of securities called by warrants or rights \| shares		1,672,452
Warrants exercise price		$ 1.68
Warrant [Member] \| Placement Agent Warrants [Member]
Class Of Stock [Line Items]
Class of warrant or right number of securities called by warrants or rights \| shares				67,830
Warrants exercise price				$ 6.45
Warrants outstanding \| shares						19,815,131
Warrant [Member] \| Armistice Capital Master Fund Ltd [Member]
Class Of Stock [Line Items]
Class of warrant or right number of securities called by warrants or rights \| shares				1,471,187
Warrants exercise price				$ 0.06
Private Placement \| October 2024 Offering [Member]
Class Of Stock [Line Items]
Issuance of common stock \| $	$ 110,000,000
warrant issued \| $	$ 275,000,000
IPO
Class Of Stock [Line Items]
Warrants exercise price											$ 75